G O Onyi

Skin, Soft Tissue, and Bone Infections Due to Mycobacterium chelonae chelonae: Importance of Prior Corticosteroid Therapy, Frequency of Disseminated Infections, and Resistance to Oral Antimicrobials Other than Clarithromycin

R. J. Wallace, Barbara A. Brown, G O Onyi · The Journal of Infectious Diseases · 1992 · 358 citations

Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms

Barbara A. Brown, Richard J. Wallace, G O Onyi et al. · Antimicrobial Agents and Chemotherapy · 1992 · 308 citations

Antimicrobial Chemotherapy, Antibiotic Resistance, Drug Resistance +18

Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus

Richard J. Wallace, A Meier, Barbara A. Brown et al. · Antimicrobial Agents and Chemotherapy · 1996 · 287 citations · Full text

Bacteriology, Pathology, Antibiotic Resistance +16

A Single 16S Ribosomal RNA Substitution Is Responsible for Resistance to Amikacin and Other 2‐Deoxystreptamine Aminoglycosides in<i>Mycobacterium abscessus</i>and<i>Mycobacterium chelonae</i>

Therdsak Prammananan, Peter Sander, Barbara A. Brown et al. · The Journal of Infectious Diseases · 1998 · 229 citations

Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy.

Rebecca W. Wilson, V A Steingrube, Erik C. Böttger et al. · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · 2001 · 210 citations